See The BCR-ABL T315I mutation compromises survival in chronic phase chronic myelogenous leukemia patients resistant to tyrosine kinase inhibitors, in a matched pair analysis
http://www.haematolo...080234.abstract
See also http://www.cmleukemi...tion-t315i.html